Royalty Pharma plc
RPRX
$35.42
$0.270.77%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -64.22% | 26.13% | 99.31% | 6.03% | -17.22% |
Total Receivables | 12.54% | 8.44% | 6.56% | 1.36% | 1.12% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -- | -- | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 94.24% | -38.54% | -76.79% | -26.75% | -77.58% |
Total Current Assets | -41.06% | 18.18% | 41.43% | 3.79% | -12.68% |
|
|||||
Total Current Assets | -41.06% | 18.18% | 41.43% | 3.79% | -12.68% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 0.00% | -- | 199.38% | -67.41% | -67.90% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 9.21% | 11.83% | 7.54% | 13.38% | 4.76% |
Total Assets | 3.77% | 9.16% | 11.24% | 13.79% | 3.13% |
|
|||||
Total Accounts Payable | -13.70% | 225.77% | -11.84% | 61.85% | 303.10% |
Total Accrued Expenses | 52.19% | 52.61% | 89.74% | 204.98% | 3.86% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -49.90% | 26.85% | 52.77% | 8.49% | 73.66% |
Total Other Current Liabilities | -49.90% | 26.85% | 52.77% | 8.49% | 73.66% |
Total Current Liabilities | 337.62% | 849.52% | 676.82% | 812.79% | -76.48% |
|
|||||
Total Current Liabilities | 337.62% | 849.52% | 676.82% | 812.79% | -76.48% |
Long-Term Debt | -7.88% | 7.81% | 7.81% | 7.82% | 24.07% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 2,092.12% | 455.90% | 1,242.22% | -50.62% | 218.13% |
Total Liabilities | 11.58% | 24.77% | 25.13% | 24.13% | 8.17% |
|
|||||
Common Stock & APIC | 0.66% | 3.33% | 2.29% | 2.52% | 1.72% |
Retained Earnings | -6.54% | 2.19% | 13.03% | 29.51% | 5.56% |
Treasury Stock & Other | 1.84% | 0.00% | -1.26% | -1.26% | -1.22% |
Total Common Equity | -1.98% | 2.91% | 6.44% | 11.91% | 3.10% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -1.98% | 2.91% | 6.44% | 11.91% | 3.10% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -3.68% | -7.85% | -4.55% | -1.67% | -7.26% |
Total Equity | -2.55% | -0.76% | 2.56% | 7.03% | -0.63% |
|